Integration of Generative AI with SAP S/4HANA for Enhanced Drug Discovery and Clinical Trial Management in Life Sciences Organizations

Abstract

The pharmaceutical industry faces unprecedented challenges in drug discovery and clinical trial management, with escalating costs, extended development timelines, and complex regulatory requirements. This research explores the integration of Generative Artificial Intelligence (AI) with SAP S/4HANA enterprise resource planning systems to address these challenges in life sciences organizations. Through comprehensive analysis and empirical evaluation, this study demonstrates how the synergy between generative <tex xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">$A I$</tex> and SAP S/4HANA can revolutionize drug discovery processes, optimize clinical trial management, and enhance overall operational efficiency. The research presents a quantitative framework for seamless integration, develops predictive models using machine learning algorithms, and evaluates performance through rigorous statistical analysis. Results indicate significant improvements in drug candidate identification (35% faster), clinical trial planning (42% reduction in timeline), and regulatory compliance (28% improvement in documentation accuracy). This paper contributes to understanding digital transformation in pharmaceutical research and provides practical implementation guidelines for life sciences organizations.

Ähnliche Arbeiten